International Conference on NEUROLOGY & BRAIN DISORDERS
  • Impact Conferences
  • 129 Cypress Landing Dr,
    North Carolina, USA
  • Phone: +1-3028277933
  • Dubai UAE |

About the Impact Neurology 2019

Impact  International Conferences welcomes you to join and share your research findings at Innovate Neurology 2019 in Dubai, UAE,  Nov 12-13, 2019.

We cordially invite all researchers, business professionals, and industry/academia representatives to Impact Neurology 2019 where we will update the community as to the latest trends in research, business strategies, current innovations and the latest technologies relevant to the Neurology and Psychiatry community. Join us and share your research findings with professionals from around the globe through thought provoking Keynote lectures, Oral presentations, Video talks and Poster presentations.

Impact  provides an excellent opportunity for the business delegates from Medical devices companies and the Pharma Industry to exhibit their products to an international audience.

The Summit will focus on the theme “Exploring the innovations in Neurology & Encephalon Disorders”.


Impact Neurology 2019 has the goal of filling the prevailing gaps in the transformation of research from Neuro surgical industry, Neurology, psychiatry to products that can benefit mankind.  We hope to facilitate this transformation via face to face meetings between research scientists and business professionals in order to promptly develop solutions to roadblocks that exist when basic research findings are translated to practical applications.

Scientific Sessions

Impact Neurology 2019 will encompass presentations of recent research findings with the objective of research and recovery from neurological disorders and Neuron infectious diseases that will benefit world health. The root motif of our conference is “Exploring the innovations in Neurology & Encephalon Disorders” and will cover a broad area of topics that will be of interest to basic and translational research scientists, surgical business executives and scientists and surgeons entrepreneurs


Impact Neurology 2019 is an outstanding event designed for CEO’s, Directors, CSO’s, Basic/Translational Research Scientists, Industry Researchers, Business Professionals and Neurology and surgery investors.


Scientifc Sessions

  • Neuropsychiatry & Rehabilitation
  • Neurobiology and Translational Medicne
  • Clinical and Experimental Neuroscience
  • CNS Disorders & Treatment
  • Schizophrenia & Mental Health
  • Neurocognitive Disorders
  • Neuroimaging & Radiology
  • Brain Disorders & Treatment
  • Alzheimer’s Disease & Dementia
  • Epilepsy & Seizures
  • Geriatric Neuropsychiatry
  • Neuro-oncology and Brain Tumors
  • Depression, Anxiety and Stress
  • Spine and Spinal Surgery
  • Parkinson’s disease & Movement Disorders
  • Neurology & Neuro Surgery
  • Brain Mapping & Traumatic brain Injury
  • Neuro Chemistry
  • Neuro Immunology
  • Neuro Genetics
  • Psychiatry & Psychosomatic Medicine
  • Geriatric and Counseling Psychology
  • Psychiatry and Psychological disorders
  • Pediatric & Child Neuro-Psychiatry
  • Clinical psychiatry 2019
  • Vascular Neuronal Transition
  • euro Pharmaceutics
  • Neuro Nursing and clinical Trails
  • Cognitive Behavourial Therapy
  • Psychiatry Research: Neuroimaging

  • Scientifc Committee Members



    Track 1: Brain Diagnosis

    The diagnosis of the brain can take many different exceptional forms and has been given many different extraordinary names. It affects 1 in 6 people's lives and costs more than $1 trillion every year in medical expenses. There are 10 million people living in the UK who have neurological conditions that have a significant impact on their quality of life. The most common neurological conditions in the UK are epilepsy, stroke, dementia, headache, and dementia. It was anticipated that there would be a lifetime possibility of the brain and other valuable fearful devices expanding. Within the UK, the prevalence of cancer is 1 in 133 for men and 1 in 185 for women. The goal of this consultation is to identify the Root Causes, Genesis, Origin, and Source of various types of Brain Issues.

    Track 2: Brain Injury and Rehabilitation

    A brain injury is a disturbance or issue with the normal functioning of the mind that may be caused by a blow, bump, or jolt to the head, by the head suddenly and violently colliding with anything, or by something entering the cranium and entering the brain tissue.

    Rehabilitation is a strict set of treatments intended to improve a person's ability to function and reduce their level of disability in the context of their surroundings. Depending entirely on a person's ability to participate in a rehabilitation programme, there are many different rehabilitation options.

    Track 3: Electroconvulsive Therapy

    While the patient is under general anaesthetic, regulated electric currents are sent across the brain during the ECT process. This results in a brief, controlled seizure that changes the brain's neurons and molecules. It is most frequently used to treat severe melancholy, depression, and psychosis when other treatments have failed. ECT is also taken into consideration as a therapy option in some cases of treatment-resistant bipolar illness.

    Track 4: Neurological disorders

    While the patient is under general anaesthetic, regulated electric currents are sent across the brain during the ECT process. This results in a brief, controlled seizure that changes the brain's neurons and molecules. It is most frequently used to treat severe melancholy, depression, and psychosis when other treatments have failed. ECT is also taken into consideration as a therapy option in some cases of treatment-resistant bipolar illness.

    Track 5: Vagus Nerve Stimulation (VNS)

    The vagus nerve, which transmits signals to regions of the brain that regulate sleep and mood, is stimulated with electrical impulses by VNS using a pulse generator that is almost the size of a stopwatch and inserted in the upper left side of the chest. Epilepsy, as well as other medical problems including sorrow, can be treated with VNS.


    The FDA has approved VNS for the treatment of depression that is difficult to treat, sorrow that doesn't get better despite taking four different drugs, or ECT.

    Track 6: Neuro-oncology & Brain Tumors

    The study of brain and medulla spinalis sequence neoplasms, such as astrocytomas, gliomas, glioblastomas multiforme, ependymomas, pontine gliomas, and brain stem tumours, is known as neuro oncology. Gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (fantastically anaplastic) Astrocytoma are some of the worst types of malignant brain cancer. Untreated survival in these cases typically amounts to only a few months, and survival with modern radiation and chemotherapy treatments may also increase that point from roughly a year to a year and a half, probably or more, depending on the patient's condition, immune function, treatments used, and the specific type of malignant brain tumour.

    Track 7: Pediatric Neurology

    Paediatric neurology, often known as child neurology, is a specialised area of medicine that deals with the diagnosis and treatment of neurological conditions in newborns, babies, children, and adolescents. Child neurology covers illnesses and issues that affect persons in certain age groups with the spinal cord, brain, peripheral nervous system, autonomic nervous system, muscle mass, and blood vessels.

    Track 8: pathophysiology of Brain Disorders

    When the brain or the way it functions is harmed or disrupted after a person is born, there is a brain disorder. A damaged brain will alter memory, feeling, and occasionally even personality. It can happen as a result of trauma such as concussion, lack of oxygen, assault, falls, accidents, and other trauma that results in degenerative diseases, brain tumours, Alzheimer's disease, and other dementias. Disorder often has little effect on intelligence, while there may be cognitive abnormalities such memory, focus, and attention issues. The civilization is thought to be seriously affected by brain illnesses.

    Track 9: Deep Brain Stimulation (DBS)

    The FDA approved Deep Brain Stimulation (DBS) for use in treating obsessive-compulsive disorder (OCD) even though it was originally developed to lessen Parkinson's disease-related tremors. Major depression and Tourette's syndrome are currently being treated using DBS. The usefulness and safety of DBS for mental health remain uncertain and its usage is heavily experimental.


    Track 10: Neuropharmacology

    A field of study known as neuropharmacology may focus on medications that have an impact on the nervous system. It is concentrated on the development of substances that may help people with neurological or psychiatric disorders. As a result, this field necessitates a thorough understanding of how the systema nervosum operates due to the manner that each medicine affects neuronal circuits, changes cellular activity, and ultimately affects how an organism behaves. Drugs that affect nervous system-regulated activities are the focus of neuropharmacology, which uses neural control to repair various functional imbalances in the body. The systema nervosum is divided into several sections, including the peripheral systema nervosum, which consists of somatic, sympathetic, and parasympathetic nerves and ganglia, and the central systema nervosum, which includes the brain and consequently the medulla spinalis. To activate or deactivate impulse transmission or to activate effector processes at brain-effector cell junctions, neurotransmitters act at synapses, or neural junctions.

    Track 11: Brain Cancer & Tumors

    Brain cancer is a condition where cancer cells (malignant cells) develop in the brain tissue (brain cancer). A tumour is a mass of cancerous tissue that develops from cancerous cells and impairs brain activities like memory, feeling, and other typical bodily functions. Malignant tumours are those made mostly of cancerous cells, and benign tumours are those made primarily of non-cancerous cells. Primary brain tumours are those that form from brain tissue, whereas metastatic or secondary brain tumours are those that have spread from other parts of the body to the brain. Neurofibromatosis, tuberous sclerosis, and a few other hereditary genetic disorders may only account for roughly 5% of brain tumours.

    Track 12: Psychology and Neuroscience

    Psychology Cognitive psychology and brain technology are two of the most in-demand and versatile areas of mental knowledge in the modern world. Every career has a fascinating passion in how the mind functions. Engineers, scientists, judges, public health and safety officials, architects, and picture designers are just a few of the people who need to learn more about how the brain processes information. Their research and the subsequent programmes have evolved into a crucial component of how institutions, businesses, and enterprises operate and flourish. Cognitive psychologists are looking for solutions in scientific contexts to issues relating to human intellectual methods, such as Alzheimer's disease, speech issues, memory loss, and sensory or notion difficulties.Tuberous sclerosis, neurofibromatosis, and a few more.

    Track 13: Mental Disorder / Mental illness / Psychiatric Disorders


    Mental disorders are typically defined as a variety of means of a person's behaviour, feelings, perceptions, or thoughts. This may be connected to particular brain functions or regions, typically in a social setting. One aspect of intellectual fitness is an intellectual disorder.


    Treatments are offered by means of a variety of intellectual fitness specialists. Important treatment options include psychotherapy and psychiatric medications. Changes in behaviour, social interventions, peer support, and self-help are further treatments. There is likely involuntary detention or a remedy in a small percentage of situations. It had been demonstrated that prevention programmes reduced depression. There are numerous discrete intellectual disease subtypes, as well as numerous distinct aspects of human behaviour and character that might become disordered.

    Track 14: Neuroinformatics and Computational Neuroscience

    Clinical data regarding the most experimental information, ontologies, metadata, analytical tools, and computational designs of the neural system are all referred to as neuroinformatics. Experiments and experimental circumstances pertaining to the genetic, molecular, structural, cellular, network, and behavioural levels in all species and configurations in both the regular and disordered states make up the majority of the information.

    From a computational standpoint, neuroinformatics examines data processing through fearful structures. Philosophy, computer technology, and informatics are the three main foundations of neuroinformatics.

    The field of study known as computational neuroscience uses mathematical tools and theories to study how the mind works. It may also include numerous techniques from physics, computer technology, and electrical engineering in order to understand how the concerned device processes information. A branch of theoretical neuroscience called computational neuroscience uses computer simulations to verify and correct the mathematical hypotheses.

    Track 15: Human Brain Mapping

    The study of the anatomy and characteristics of the brain and spinal cord using imaging, immunohistochemistry, molecular and optogenetics, stem cell and cell biology, engineering, neurophysiology, and nanotechnology is specifically described as brain mapping.

    The development and enhancement of photo capture, representation, analysis, visualisation, and interpretation methodologies are essential to the ongoing evolution of brain mapping techniques. The middle of the mind mapping's mapping component is where functional and structural neuroimaging is located.

    Track 16: Excitotoxic cell damage

    Excitotoxicity refers to the pathological process whereby glutamate or a related excitatory amino acid damages and kills nerve cells under conditions such those that result from prolonged exposure. This happens when the excitatory neurotransmitter receptors, such as those for N-methyl-D-aspartate (NMDA) or AMPA, are overactive. Such excitotoxic neuronal death may occur as a byproduct of brain, spinal cord, or other injuries or injury linked to a number of human disease conditions. The neuronal cell death associated with neurodegenerative diseases has been explained by a number of mechanisms, including accumulation of oxidising free radicals, impairment of mitochondrial function, activation of apoptotic programmes, and elevation of intracellular calcium.

    Day-1: Nov 12, 2019
    program time program session
    09:00-09:30 Registrations
    09:30-10:00 Inauguration Ceremony
    10:00-10:45 Keynote Session I
    10:45-11:00 Refreshment Break
    11:00-11:45 Keynote Session II
    11:45-12:00 Refreshment Break
    12:00-14:45 Break Out Session I
    14:45-15:00 Refreshment Break
    15:00-18:00 Break Out Session II
    Day-2: Nov 13, 2019
    program time program session
    10:00-10:45 Keynote Session III
    10:45-11:00 Refreshment Break
    11:00-13:00 Break Out Session III
    13:00-13:15 Refreshment Break
    13:15-15:15 Poster Presentations
    15:15-15:30 Refreshment Break
    15:30-17:30 Break Out Session IV
    17:30-18:30 Closing Ceremony

    Our Conferences